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Results

Introduction

Materials & Methods
IVD Extraction Method
1. Betadine solution was used to coat the tails
2. Caudal Discs (C4-5 to C7-8) were targeted
3. Fascia and muscle were then cut away with scalpels,
vertebrae were separated heavy duty clippers, and scalpels
were used to cut out IVDs.
4. IVDs were immediately placed in empty 120mL containers
before starting decellurization.
Figure 2: Freshly isolated bovine caudal
IVD immediately prior to the initiation of
decellularization. Area inside the blue
ellipse indicates the NP region of the
IVD while the area between the green
and blue ellipses illustrate the AF region.

Decell Solution 1
 0.1% decell solution was composed of 2.21mM ethylene
diamine tetraacetic acid (EDTA) and, 0.1% sodium dodecyl
sulfate (SDS) dissolved into phosphate buffered saline (PBS).

Assay completed in order to determine total glycosaminoglycan content of fresh and decellularized IVD samples
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(Figure 3): Nucleus Pulposus GAG Content. Comparison of
average GAG content in the NP of decelled IVDs to the NP of
fresh IVDs. Results indicate a dramatic reduction in GAG content
in decelled IVDs compared to fresh. (n=3/group)

(Figure 4): Annulus Fibrosus GAG Content. Comparison of
average GAG content in the AF of decelled IVDs to the NP of
fresh IVDs. *Data point missing method 3. (n=3/group)

PicoGreen Assay
Assay completed in order to determine DNA content in fresh and decellularized IVD samples
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(Figure 5): Nucleus Pulposus DNA Content. Comparison of
average DNA content in the NP of decelled IVDs to the NP of
fresh IVDs. Results indicate a dramatic reduction in bovine DNA
content in decelled IVD NPs compared to fresh. *Data point in
method 2 missing. (n=3/group)

(Figure 6): Annulus Fibrosus DNA Content. Comparison of
average DNA content in the AF of decelled IVDs to the NP of
fresh IVDs. Results indicate a dramatic reduction in bovine DNA
content in decelled IVD AFs compared to fresh. *Data points in
methods 1 and 3 missing. (n=3/group)
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Decellurization Method
1. Two IVDs IVDs were kept at -20°C for use as fresh, control
samples. The other 9 IVDs were thawed and they were
divided into three groups of three.
2. Three IVDs were put in 100 mL of 0.1% SDS decell solution
and six were put in 100 mL 0.05% decell solution. These
containers were left on an orbital shaker at 150rpms at room
temperature for 24 hours.
3. IVDs were subjected to ultrasonication for 10 minutes at 40
kHz. Agitation and sonication cycles repeated every 24 hours
for a total of 4 cycles for three of the IVDs in 0.05% SDS and 6
cycles for the remaining 6 IVDs.
4. The respective decell solutions were refreshed for during each
sonication cycle.
5. The IVDs were then removed from their containers, and were
thoroughly rinsed in 1X PBS on an orbital shaker at 150rpms
at room temperature for 24 hours.
6. After 24 hours, each IVD was removed from its container and
cut in half using a scalpel. One half of each IVD was placed in
a tissue cassette and placed in10% neutral buffered formalin
in preparation for be fixed for histological analysis, and the
other half was frozen at -20°C for use in biochemical
analysis (DMMB and PicoGreen assay).
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 Decellularization of a targeted tissue is becoming a popular
method by which to generate a tissue-specific scaffold for use in
tissue regeneration applications. When using this approach to
generate a scaffold, it is imperative to completely decellularize the
tissue while maintaining the tissue-specific extracellular matrix
(ECM) components / micro-architecture.
 Herein, we evaluated two different decellularization solutions and
assessed their ability to fully remove bovine cells from the NP and
AF regions of cow tail IVDs, while attempting to maintain as much
GAG (an ECM component which contributes significantly to the
mechanical function of the IVD) as possible.
 We also observed the effect of altering decellularization time on
treatment efficacy. We had 3 IVDs go through 6 cycles of
sonication and decell in 0.05% SDS solution and 3 IVDs go
through 4 cycles of sonication and decell in 0.05% SDS solution
(the 3 IVDs in 0.1% SDS solution went through 4 cycles).
 Our results indicate:
 Decell method #1 resulted in a 82% reduction of DNA content
in the NP and a 96% reduction in the AF as compared to fresh
tissue. Decell method #2 resulted in a 56% reduction of DNA
content in the NP and a 92% reduction in the AF as compared
to fresh tissue. Decell method #3 resulted in a 62% reduction
of DNA content in the NP and a 96% reduction in the AF as
compared to fresh tissue. From these results we concluded
that Decell method #1 was the most efficient at removing DNA
from both NP and AF regions of the bovine caudal IVD.
Overall, these decell methods appeared to work much better
for AF than for NP for removing of DNA.
 The data from the DMMB assay illustrate a reduction in NP GAG
content but wide variability for GAG content in the AF. We will
repeat GAG content analysis from the AF.

Conclusions and Future Work
0
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Decell Solution 2
 0.05% decell solution was comprised of was 2.21mM EDTA,
and 0.05% SDS dissolved into PBS.
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Figure 1: Schematic illustrating the anatomic
location of the IVD between the vertebral
bodies of the spine from a top view and the
two primary components of the IVD: the
nucleus pulposus (NP) and annulus fibrosus
(AF).2

DMMB Assay:

DNA Content (ng/mg)

Lower back pain (LBP) is a significant burden affecting the
majority of our society. Although LBP is multifactorial; it has
been shown that LBP can be caused by degenerating
intervertebral discs (IVDs), which provide flexibility and shock
absorbance for the vertebral column. Twenty percent of teens
have mild IVD degeneration, which progresses with age and
sixty percent of those over age 70 have severely degenerated
IVDs.1 Current solutions are conservative or surgical, and
there is significant room for improvement. The first goal of our
project is to create a fully decellularized bovine caudal IVD to
be used as a scaffold on which to seed adult human stem
cells in an attempt to engineer a healthy, replacement IVD for
patients suffering from IVD degeneration and lower back pain.

Discussion
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 Looking forward, various steps of the decell process should
be observed to see how much each step helps in clearing
DNA from the IVDs. This would help to determine the most
effective step in the current decellularization process. We
also would be more careful with the IVDs to try to avoid
outliers and low dry weights. More variables must be tested
to pinpoint exactly what removes DNA in the IVDs. Once that
chemical / method is found, it can be optimized in order to
effectively remove DNA while maintaining GAG content.
 Currently, our lab is comparing 0.05% SDS decell solution to
a new formulation of decell solution. Also, use of a snapfreeze method with liquid nitrogen is being compared to a
longer, slower freeze at -80oC. Overall, 4 IVDs are being
analyzed and a fifth IVD is being used as a control. The
intention is to perform a DMMB assay, a PicoGreen assay,
and a histological analysis before the end of the semester.
 In the future, we will fine tune procedural errors and be more
careful when conducting assays so meaningful results can
be obtained. These results should provide more definite
conclusions that show success in decellularizing the IVDs to
our goals for DNA content and GAG content. We will also
work towards adding human stem cells to our scaffolds.
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(Figure 7): IVD Histology Staining. Representative H&E
staining of A-B) decellularized and C-D) fresh bovine IVDs. The
black/dark purple regions are cell nuclei and the pink/light purple
is extracellular matrix (ECM). Results indicate a reduction in cell
nuclei, but minimal loss in ECM staining.

(Figure 8): Spinal Anatomy. Diagram showing the
location of the IVD between vertebral bodies from a
side view and demonstrating how it provides shock
absorbance and flexibility in the spine.3
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Decell Method Key:
Method 1: 0.1% SDS solution, 4 cycles (IVDs 1-3)
Method 2: 0.05% SDS solution, 4 cycles (IVDs 4-6)
Method 3: 0.05% SDS solution, 6 cycles (IVDs 7-9)
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